FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine, namely to ophthalmology, and can be applied for treatment of different diseases of eyes. Eye drops contain methylene blue, diphenhydramine hydrochloride, naphazoline hydrochloride, hydroxypropylmethylcellulose, boric acid, polyvinylpyrrolidone and distilled water in defined ratio of components.
EFFECT: invention ensures non-toxic and non-irritating anti-inflammatory, anti-infectious, anti-allergic action.
4 ex
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
EYE DROPS POSSESSING ANTIINFLAMMATORY AND ANTIBACTERIAL ACTION | 2012 |
|
RU2506086C1 |
OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
THERAPEUTIC AGENT FOR TREATING ALLERGIC AND VIRAL OCULAR DISEASES IN FORM OF GEL OR GEL-LIKE DROPS | 2015 |
|
RU2595244C1 |
OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
EYE DROPS | 2012 |
|
RU2504372C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
Authors
Dates
2013-09-27—Published
2012-09-19—Filed